SEC Form 4 · accession 0001645627-17-000054
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
May 3, 2017
Accepted (ET)
May 5, 2017 · 12:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 3, 2017 | P | 1,000 | $0.0806 | A | 20,609,949 | D | |
| Common Stock | May 3, 2017 | P | 1,000 | $0.081 | A | 20,610,949 | D | |
| Common Stock | May 3, 2017 | P | 1,000 | $0.0789 | A | 20,611,949 | D | |
| Common Stock | May 3, 2017 | P | 1,000 | $0.079 | A | 20,612,949 | D | |
| Common Stock | May 3, 2017 | P | 1,000 | $0.079 | A | 20,613,949 | D | |
| Common Stock | May 3, 2017 | P | 1,000 | $0.079 | A | 20,614,949 | D | |
| Common Stock | May 3, 2017 | P | 1,000 | $0.076 | A | 20,615,949 | D | |
| Common Stock | May 3, 2017 | P | 1,000 | $0.076 | A | 20,616,949 | D | |
| Common Stock | May 3, 2017 | P | 1,000 | $0.0739 | A | 20,617,949 | D | |
| Common Stock | May 3, 2017 | P | 1,000 | $0.0728 | A | 20,618,949 | D | |
| Common Stock | May 3, 2017 | P | 1,000 | $0.073 | A | 20,619,949 | D | |
| Common Stock | May 3, 2017 | P | 1,000 | $0.0744 | A | 20,620,949 | D | |
| Common Stock | May 3, 2017 | P | 1,000 | $0.0745 | A | 20,621,949 | D | |
| Common Stock | May 3, 2017 | P | 1,000 | $0.0745 | A | 20,622,949 | D | |
| Common Stock | May 3, 2017 | P | 1,000 | $0.0745 | A | 20,623,949 | D | |
| Common Stock | May 3, 2017 | P | 936 | $0.0753 | A | 20,624,885 | D | |
| Common Stock | May 3, 2017 | P | 64 | $0.08 | A | 20,624,949 | D | |
| Common Stock | May 3, 2017 | P | 1,000 | $0.08 | A | 20,625,949 | D | |
| Common Stock | May 3, 2017 | P | 1,000 | $0.079 | A | 20,626,949 | D | |
| Common Stock | May 3, 2017 | P | 1,000 | $0.079 | A | 20,627,949 | D | |
| Common Stock | May 3, 2017 | P | 1,000 | $0.076 | A | 20,628,949 | D |
Table II — derivative securities
No Table II lines on this filing.